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1062MP-123 Efficacy Trends With the Acorn Cardiac Support Device: 
Two-Year Follow-Up 
Wolfoano F. Konertz, Franz X. Kleber, Simon Dushe, Holger Hotz, Katdn Stantke, 
Lorinda Austin, Robert Walsh, Charita, Berlin, Germany, Unfal/Krankenhaus, Berlin, 
Germany. 
Background:Ventdcular diastolic support with the Acorn Cardiac Support Device (CSD), 
a preformed knitted polyester device placed around the heart, has been shown to reduce 
wall stress/stretch, thus preventing left ventricular (LV) remodeling, and improving LV 
function in heart failure (HF) animal models. The present study was designed to explore 
the safety of the CSD and determine potential efficacy in HF patients including long-term 
follow-up. Methods: From Apd11999 to July 2000, 29 patients received the Cardiac Sup- 
port Device (CSD) during an initial safety study; 17 pts. had concomitant valve repair or 
replacement (15 mitral), and 12 received only the CSD. Most pts. (26/29) suffered from 
idiopathic erdiomyopathy, and 3 were in NYHA class IV, 15 in class III and 11 in class II 
(all class II pts had a history of class III or IV). All were on intensive medical treatment 
and in stable condition. Results: There were no intraoperative complications, and no 
adverse events or deaths were considered device-related. At 6 and 12-month follow-up, 
patients showed improvement in NYHA class, LV ejection fraction (EF), LV end-diastolic 
dimension (EDD), and end-systolic dimension (ESD). The improvements were main- 
tained at 24-month follow-up. Conclusion:Results from the study indicate that the device 
is safe with trends towards efficacy at six and twelve months and maintained at two 
years.Based on these data, randomized clinical trials have been initiated to evaluate the 
efficacy of the CSD in heart failure patients. 
Pre-lmplant 12 Months 24 Months 
LVEDD(mm) 1 74.2 ±-6.4 (27) 66.6 + 17.3 (17)* 64.7 + 9.7 (7)* 
LVESD(rnm) 1 65.6 + 7.7 (25) 57.4 + 10.5 (17)* 56.0 +15.3 (7)* 
LVEF% 1 21.0 ± 6.8 (29) 30.7 ± 12.6 (17)* 34.4 ±12.5 (7)* 
NYHA Class 2 2.8 ± 0.6 (29) 1.6 ± 0.7 (17)* 1.7 _+ 1.0 (7)* 
Mean ± (s.d.), *p~O.05, it test, 2Mann-Whitney test 
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1062MP-124 Chronic Reeynchronization Therapy Does Not Alter Left 
Ventricular Geometry 
Husem H. Farah, Seung-Joon Lee, Esperenza Viloria, Teresa De Marco, Leslie Saxon, 
Elyse Foster, The VIGOR-CHF Investigators, University of California, San Francisco, 
California. 
Background: Left bundle branch block, often found in dilated cardiomyopathy, leads to 
mechanical dyssynchrony, which may contribute to ventricular remodeling. Chronic 
resynchronization therapy (CRT) with biventricular stimulation (BVS) in patients with 
dilated cardiomyopathy and left bundle branch block was shown to improve left ventdcu- 
lar systolic performance and reduce end-systolic volume in patients enrolled in the 
VIGOR-CHF study. The improvement in left ventdcular systolic function may be accom- 
panied by improvement in left ventdcular geometry. We hypothesized that the improve- 
ment in systolic function and reduction in left ventricular end systolic volume seen with 
BVS in these patients would be accompanied by a reduction in the sphericity of the left 
ventricle. 
Methods: Adequate 2D echocardiogrephic 4-chamber views were available for analysis 
at pro-implantation and after 12 weeks of continuous BVS in 35 pts of the VIGOR study: 
19(54%) M, and 16(46%) F, age 20-82 years, mean of 59 + 14 years; 6(17%) ischemic 
cardiomyopathy and 26(83%) non-iechemic ardiomyopathy; QRS duration 177 + 34 
msec. The maximum short axis and long axis dimensions were measured at end-diastole 
and end-systole.Sphericity index (SI) was calculated at end-systole (es) and end-diastole 
(ed) by dividing the respective long axis dimensions by the short axis dimensions 
(Sl=long axis/short axis). Delta was calculated by subtracting the SI at end-diastole from 
SI at end-systole. 
Results: SI (es) at pro-implantation was 1.35±0.15 Versus 1.34_+0.19 after 12 weeks of 
BVS (P=0.28). Sl(ed) was 1.30¢0.13 at pra-implantation Versus 1.33±O.18 after 12 
weeks of BVS (P=0.28). Delta was 0.052~0.081 at pro-implantation Versus 0.057±0.070 
after 12 weeks of BVS (P=0.79). 
Conclusion: The sphericity index was markedly abnormal at baseline in these patients. 
Despite improvement in the left ventdcular volumes and myocardial performance, as 
shown previously, the sphedcity index did not change. Thus, in this small group of mark- 
edly abnormal patients, we were unable to demonstrate improvement in left ventricular 
geometry as measured by left ventdcular sphedcity index after 12 weeks of continuous 
biventdcular stimulation. 
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1062MP-125 Link Between Systolic and Diastolic Dysfunction In 
Hypertensive Subjects With Inappropriate Left 
Ventricular Hypertrophy: The HyperGEN Study 
Giovanni de Simorl~, Dalane W. Kitzman, Vlttodo Palmieri, Jennifer E. Liu, Jonathan N. 
Bella, Albert Oberman, Paul N. Hopkins, D. C. Rao, Donna K. Arnett, Richard B. 
Devereux, WeN Medical College, New York, New York, Fedarico I/Universi~ Naples, 
Italy. 
Background: Left ventricular (LV) mass (M) level exceeding the compensatory needs for 
hemodynamic load, named inappropriate (iLVM), is associated with depressed LV cham- 
ber and midwall systolic function. However, there is little information on relation of iLVM 
to diastolic function. 
Methods: We examined 1835 subjects (1513 hypertensive, 863 obese) without preva- 
lent cardiovascular disease, participating in the HyperGEN study. LVM was predicted by 
stroke work (systolic blood pressure * Doppler stroke volume), sex and height (m 2'7) 
dedved in 177 normotansive, non-obese, non-diabetic participants. Values of observed/ 
predicted LVM > t .35 (95 th percentile) defined iLVM. 
Results: Among hypertensives, 161 subjects with iLVM (11%) had equal age (54 yrs) 
and similar antihypertensive treatment, but were more obese than patients with appropd- 
ate LVM (p<O.O00t). After adjusting for age, sex, race, body mass index, heart rate and 
antihypertensive therapy, patients with iLVM had more dilated LV (5.46 vs 5.08 cm), pro- 
longed isovolumic relaxation time (IVRT, 85 vs 82 msec, p<0.003), slightly increased 
Doppler E/A ratio (1.02 vs 1.01 m/sec, p=0.05), and no difference in E-velocity decelera- 
tion time. IVRT was similarly prolonged in 25 hypertensive participants with ejection frac- 
tion (EF) <- 40%, when iLVM was either present (12 of 161) or absent (13 of 1352, 
p<0.0001). Patients with low EF and iLVM were older (60 yrs, p<O.02), and had higher E/ 
A ratio (1.17 m*sec, p<0.03) than all other patients, while deceleration of E-velocity 
tended to be faster. In hierarchical regression modeling, IVRT was sequentially adjusted 
for significant covadates, including demographics, heart rate and LV load; after control- 
ling for covariates, prolonged IVRT remained independently related to greater observed/ 
predicted LVM (+11 msec per +1%, p<0.0001), and low midwall shortening (+1.35 msec 
per -1%, p<0.01 ). 
Conclusions: LVM exceeding the compensatory needs for workload is associated with 
delayed LV relaxation as well as midwall systolic dysfunction, independently of demo- 
graphic and hemodynamic onfounders. When LV chamber is depressed, the excess 
LVM also correlates with features of pseudo-normal LV filling pattam. 
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1062MP-126 Mitral Annular  Geometric Changes After the 
Implantation of a Left Ventricular Shape Changing 
Device: A Reel-Time Three-Dimensional 
Echocardiogrepic Study in Canine With Dilated 
Cardiomyopathy 
Hua Yano. Takahiro Shiota, Hiroyuki Tsujino, Lisa A. Cardon, Masami Takagaki, Kiyotaka 
Fukamachi, Yoshie Ochiai, Kazuyoshi Doi, Patdck M. McCarthy, James D. Thomas, 
Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: It has been previously reported that Myocor TM Myosplint~) changes the 
shape of left ventricle (LV), reduces the effective LV radius and wall stress and therefore 
improves LV systolic function. This study focused on measuring geometdc changes of 
the mitrel valve annulus in dogs with Myosplint implantation by real-time 3-dimensional 
echocardiogrephy (RT3DE). 
Methods: In 9 dogs (test group), dilated cardiomyopathy (DCM) and heart failure were 
induced by rapid ventricular pacing at 230 beats/rain for 3 to 4 weeks. Myosplint devices 
were implanted perpendicular to the LV long axis and the walls were drawn together to 
change the shape from globular to bilobular. RT3DE was performed prior to surgery 
through the closed chest (Baseline, Test), prior to device tightening (Pre-T) and post- 
tightening (Post-T). An additional 6 normal dogs were evaluated through the closed chest 
and were included as control (Normal). Mitral valve leaflet hinge points in the end dias- 
tolic (ED) and end systolic (ES) phases, in 9 rotational planes, were identified and the 
mitrel annulus was then reconstructed in 3D spatial axes. The area and circumference 
(Circ) of mltral annulus, its motion along the apical long axis, LV ED and ES volumes and 
ejection fraction (EF) were calculated by RT3DE. 
Results: At baseline, Test group had larger mitral annular areas (ED: 8.9±1.9 vs 
4.1±0.8cm 2,ES: 8.7±2.0 vs 4.1±0.5 cm 2, p<O.01 ) and Circ (ED: 10.9±1.2 vs 7.4¢1.0 cm, 
ES: 10.8±1.2 vs 7.4±0.5 cm, p<0.01 ) with less motion (2.4±1.7 vs 5.7±3.3 ram, p<0.05) 
than the normal group. Compared to Pre-T values, the area (ED:6.7±1.3 vs 7.9±1.3cm 2,
p<0.01, ES: 6.4¢1.1 vs 7.7±1.9 cm 2, p<0.05) and Circ (ED: 9.3±0.7 vs 9.9±0.8 cm, ES: 
9.1±0.7 vs 9.7±1.0 cm, p<0.05) in Post-T were significantly reduced and motion (3.4±1.6 
vs 2.4±1.7 mm, P>O.05) had a tendency to increase. Those results were associated with 
LV volume reduction (ED:58.8±9.6 vs 82.9±11.3 ml, ES: 38.8±6.6 vs 64.3±9.8 ml, p < 
0.01)and suggested improved LV morphology and function (EF: 33.7±7.2 vs 22.3±8.0 %, 
p < 0.01). 
Conclusion: Myosplint implantation and shape change of the LV may improve mitral 
annular geometry and LV function in DCM subjects and RT3DE is an effective means of 
evaluating these changes. 
